Evidence map›Paper›PMID 26469186›Full record

ArticlePloS one2015

Changes in HIV Outcomes Following Depression Care in a Resource-Limited Setting: Results from a Pilot Study in Bamenda, Cameroon.

Bradley N Gaynes, Brian W Pence, Julius Atashili, Julie K O'Donnell, Alfred K Njamnshi, Mbu Eyongetah Tabenyang, Charles Kefie Arrey, Rachel Whetten, Kathryn Whetten, Peter Ndumbe

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Bradley N GaynesDepartment of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, NC, United States of America.
Brian W PenceDepartment of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, United States of America.
Julius AtashiliUniversity of Buea, Buea, Cameroon.
Julie K O'DonnellDepartment of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, NC, United States of America.
Alfred K NjamnshiDepartment of Internal Medicine (Neurology Unit), the University of Yaoundé I, Yaoundé, Cameroon.
Mbu Eyongetah TabenyangHIV/AIDS Treatment Center, Bamenda Hospital, Bamenda, Cameroon.
Charles Kefie ArreyRegional Technical Group for the fight against HIV North West region, Bamenda Hospital, Bamenda, Cameroon.
Rachel WhettenDuke Global Health Institute, Duke University, Durham, NC, United States of America.
Kathryn WhettenDuke Global Health Institute, Duke University, Durham, NC, United States of America.
Peter NdumbeDepartment of Biomedical Sciences, University of Buea, Cameroon; Department of Microbiology and Immunology, University of Yaoundé I, Yaoundé, Cameroon.
University of North Carolina at Chapel Hill · USUniversité de Yaoundé I · CMBamenda University of Science and Technology · CMDuke Institute for Health Innovation · USDuke University · USUniversity of Buea · CM

Funding

Social and Behavioral Sciences CoreP30AI064518 · NIAID · DUKE UNIVERSITY · PI Nwora Lance Okeke · 2005 to 2026
$50.5M
UNC CLINICAL AND TRANSLATIONAL SCIENCE AWARD: BPCAUL1RR025747 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$44.6M
UNC Clinical Translation Science Award-K12 Scholars Program (KL2)KL2RR025746 · NCRR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI RUNGE, MARSCHALL S. · 2008 to 2011
$9.0M
Training in Infectious Disease Epidemiology (TIDE)T32AI070114 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Brian W Pence · 2007 to 2026
$4.0M
Adaptation of a Depression Treatment Intervention for HIV Patients in CameroonR34MH084673 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI GAYNES, BRADLEY N · 2009 to 2011
$627k
NCRR NIH HHS KL2 RR025746NCRR NIH HHS KL2RR025746NCRR NIH HHS UL1 RR025747NCRR NIH HHS UL1RR025747NIAID NIH HHS P30 AI064518NIAID NIH HHS T32 AI070114NIMH NIH HHS R34 MH084673PHS HHS TLRR025745
6 · The paper itself

Abstract

backgroundLittle is known about how improved depression care affects HIV-related outcomes in Africa. In a sample of depressed HIV patients in a low income, sub-Saharan country, we explored how implementing measurement-based antidepressant care (MBC) affected HIV outcomes over 4 months of antidepressant treatment.

methodsAs part of a project adapting MBC for use in Cameroon, we enrolled 41 depressed HIV patients on antiretroviral therapy in a pilot study in which a depression care manager (DCM) provided an outpatient HIV clinician with evidence-based decision support for antidepressant treatment. Acute depression management was provided for the first 12 weeks, with DCM contact every 2 weeks and HIV clinician appointments every 4 weeks. We measured HIV clinical and psychiatric outcomes at 4 months.

resultsParticipants were moderately depressed at baseline (mean Patient Health Questionnaire [PHQ] score = 14.4, range 13.1, 15.6). All HIV clinical outcomes improved by four month follow-up: mean (range) CD4 count improved from 436 (2, 860) to 452 (132, 876), mean (range) log-viral load decreased from 4.02 (3.86, 4.17) to 3.15 (2.81, 3.49), the proportion with virologic suppression improved from 0% to 18%, mean (range) HIV symptoms decreased from 6.4 (5.5, 7.3) to 3.1 (2.5, 3.7), the proportion reporting good or excellent health improved from 18% to 70%, and the proportion reporting any missed ARV doses in the past month decreased from 73% to 55%. Concurrently, psychiatric measures improved. The mean (range) PHQ score decreased from 14.4 (13.1, 15.6) to 1.6 (0.8, 2.4) and 90% achieved depression remission, while mean maladaptive coping style scores decreased and mean adaptive coping scores and self-efficacy scores improved.

conclusionIn this pilot study of an evidence-based depression treatment intervention for HIV-infected patients in Cameroon, a number of HIV behavioral and non-behavioral health outcomes improved over 4 months of effective depression treatment. These data are consistent with the hypothesis that better depression care can lead to improved HIV outcomes.

Indexed as

AdultAgedAntidepressive AgentsAnti-Retroviral AgentsCameroonCD4 Lymphocyte CountDepressionEvidence-Based PracticeFemaleHIV InfectionsHumansMaleMiddle AgedPilot ProjectsTreatment OutcomeViral LoadAntidepressive AgentsAnti-Retroviral Agents

Identifiers

PMID26469186
PMCPMC4607444
OpenAlexW2271323525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.